title: [Evaluation of antianginal effectiveness of nicardipine in patients with angina pectoris].
abstract: The new calcium antagonist nicardipine was studied for its potency in 73 patients with coronary heart disease concurrent with angina pectoris, including 16 with vasospastic angina. Nicardipine given in a mean daily dose of 70.1 +/- 12.4 mg induced an increase in exercise test duration by 1-2 min in 71.9% of the patients as compared with placebo. The agent was slightly less potent than nifedipine. In vasospastic angina, nicardipine was effective in 81.3% of the patients.
authors.forename: A B
authors.initials: AB
authors.lastname: Guliev
authors.forename: A B
authors.initials: AB
authors.lastname: Sumarokov
authors.forename: I Iu
authors.initials: IIu
authors.lastname: Mironova
authors.forename: B A
authors.initials: BA
authors.lastname: Sidorenko
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy*; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D005080:Exercise Test; D006801:Humans; D009529:Nicardipine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D009529:Nicardipine
vernacular_title: Otsenka antianginal'noĭ éffektivnosti nikardipina u bol'nykh so stenokardieĭ.